Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India

Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India

Hepatitis C virus (HCV) is a global public health problem, but advancements in HCV treatment have improved the cure rate. This study evaluated the effectiveness of direct-acting antivirals (DAAs) in HCV-infected patients from May 2021 to April 2023 in collaboration with tertiary care hospitals in We...

Full description

Bibliographic Details
Main Authors: Sagnik Bakshi, Partha Chattopadhyay, Mahiuddin Ahammed, Raina Das, Moumita Majumdar, Supradip Dutta, Shreyasi Nath, Anwesha Ghosh, Uttaran Bhattacharjee, Upasana Baskey, Provash Chandra Sadhukhan
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Viruses
Subjects:
direct-acting antivirals (DAAs)
genotypes
Hepatitis C virus (HCV)
non-responder
sustained virologic response (SVR)
Online Access:https://www.mdpi.com/1999-4915/17/2/269

Internet

https://www.mdpi.com/1999-4915/17/2/269

Similar Items